OCS
Oculis Holding AG · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website oculis.com
- Employees(FY) 28
- ISIN nan
Performance
-6.58%
1W
+9.73%
1M
-4.96%
3M
+25.6%
6M
+7.48%
YTD
+15.17%
1Y
Profile
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Investment Analysis Report: OCS
Overview
OCS is a company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $459.3 million. In this report, we will conduct a detailed analysis of OCS focusing on various perspectives including Valuation, Financial Health, Ear...
Technical Analysis of OCS 2024-05-10
Overview:
In analyzing the technical indicators for OCS stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been declining, indicati...
Recent News & Updates
- 2024-05-08 16:10
- 2024-05-08 16:05
- 2024-05-08 04:10
- 2024-05-08 04:05
- 2024-05-07 16:05
Oculis Publishes Invitation to the Annual General Meeting(GlobeNewswire)
- 2024-05-07 04:05
Oculis Publishes Invitation to the Annual General Meeting(Globenewswire)
- 2024-05-06 06:30
- 2024-05-05 18:30
- 2024-04-29 16:05
Oculis Publishes Invitation to the Annual General Meeting(GlobeNewswire)
- 2024-04-29 04:05
Oculis Publishes Invitation to the Annual General Meeting(Globenewswire)
- 2024-04-22 09:27
- 2024-04-22 08:34
- 2024-04-21 21:27
- 2024-04-11 08:55
- 2024-04-10 20:55
- 2024-04-10 06:30
- 2024-04-09 18:30
- 2024-04-08 06:30
- 2024-04-07 18:30
- 2024-04-04 06:30
Oculis to Participate at Upcoming April Investor Conferences(GlobeNewswire)
- 2024-04-03 18:30
Oculis to Participate at Upcoming April Investor Conferences(Globenewswire)
- 2024-03-18 06:30
- 2024-03-17 18:30
- 2024-02-28 06:30
- 2024-02-27 17:30
- 2024-01-31 20:55
- 2024-01-29 06:30
Oculis to Present at Upcoming February Investor Conferences(GlobeNewswire)
- 2024-01-28 19:50
- 2024-01-28 17:30
Oculis to Present at Upcoming February Investor Conferences(Globenewswire)
- 2024-01-22 06:30
Page 1 of 3
previousnext